Showing results (11-20 of 22) with videos related to
Sort By:
Pageof 3
Cancer|May 27, 2003
Nausea and emesis remain significant problems of chemotherapy despite prophylaxis with 5-hydroxytryptamine-3 antiemetics: a University of Rochester James P. Wilmot Cancer Center Community Clinical Oncology Program Study of 360 cancer patients treated in the communityJane T Hickok, Joseph A Roscoe, Gary R Morrow, et al.Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|May 25, 2002
Temporal interrelationships among fatigue, circadian rhythm and depression in breast cancer patients undergoing chemotherapy treatmentJoseph A Roscoe, Gary R Morrow, Jane T Hickok, et al.Cancer|November 2, 2004
Patient expectation is a strong predictor of severe nausea after chemotherapy: a University of Rochester Community Clinical Oncology Program study of patients with breast carcinomaJoseph A Roscoe, Peter Bushunow, Gary R Morrow, et al.Journal of the Society for Integrative Oncology|June 2, 2006
Exploratory analysis of the usefulness of acupressure bands when severe chemotherapy-related nausea is expectedJoseph A Roscoe, Pascal Jean-Pierre, Gary R Morrow, et al.Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|August 6, 2011
Ginger (Zingiber officinale) reduces acute chemotherapy-induced nausea: a URCC CCOP study of 576 patientsJulie L Ryan, Charles E Heckler, Joseph A Roscoe, et al.Cancer|August 12, 2004
Cancer patients' expectations of experiencing treatment-related side effects: a University of Rochester Cancer Center--Community Clinical Oncology Program study of 938 patients from community practicesMaarten Hofman, Gary R Morrow, Joseph A Roscoe, et al.Journal of Pain and Symptom Management|April 29, 2005
Acustimulation wrist bands are not effective for the control of chemotherapy-induced nausea in women with breast cancerJoseph A Roscoe, Sara E Matteson, Gary R Morrow, et al.Breast Cancer Research and Treatment|March 9, 2005
Effect of paroxetine hydrochloride (Paxil) on fatigue and depression in breast cancer patients receiving chemotherapyJoseph A Roscoe, Gary R Morrow, Jane T Hickok, et al.The Lancet. Oncology|October 4, 2005
5-Hydroxytryptamine-receptor antagonists versus prochlorperazine for control of delayed nausea caused by doxorubicin: a URCC CCOP randomised controlled trialJane T Hickok, Joseph A Roscoe, Gary R Morrow, et al.Lancet (London, England)|September 6, 2005
Gabapentin for hot flashes in 420 women with breast cancer: a randomised double-blind placebo-controlled trialKishan J Pandya, Gary R Morrow, Joseph A Roscoe, et al.Pageof 3